Five Prime Therapeutics (NASDAQ: [[ticker:FPRX]]) announced that founder Lewis “Rusty” Williams plans to transition from CEO to executive chairman next year. Williams founded South San Francisco, CA-based Five Prime in 2001 and then shifted from CEO to executive chairman in 2003. He returned as CEO in 2011. Five Prime, which is developing drugs to treat cancer and inflammatory diseases, says that Williams will continue to lead the company until a new chief executive has been appointed.
Author: Frank Vinluan
Xconomy Editor Frank Vinluan is a business journalist with experience covering technology and life sciences. Based in Raleigh, he was a staff writer at the Triangle Business Journal covering technology, biotechnology and energy before joining MedCityNews.com as North Carolina bureau chief. Prior to moving to North Carolina’s Research Triangle in 2007 he held business reporting positions at The Des Moines Register and The Seattle Times.
View all posts by Frank Vinluan
